.
BIO financial statements
* Numbers in millions
| Capitalization * | 1 674 |
|---|---|
| EV * | 1 537 |
| Number of shares * | 40 |
| EPS | -0,79 |
| Revenue * | 484 |
| Net income * | -31 |
| Operating profit * | -3 |
| Total liabilities * | 690 |
| Net debt * | 398 |
| Total assets * | 1 131 |
| Equity * | 442 |
| Cash and investments * | 89 |
.
BIO valuation
| P/E | -53,31 |
|---|---|
| P/B | 3,79 |
| P/S | 3,46 |
| E/P | -2 |
| P/FCF | -38,30 |
.
BIO profitability
| ROE | -7% |
|---|---|
| ROA% | -3% |
| ROIC% | 0% |